Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

DPH 1,169.00 +1.00 (0.09%)
price chart
Dechra Pharmaceuticals PLC, Agrees Acquisition of US-based Putney, Inc for ...
Dechra Pharmaceuticals PLC (LSE: symbol DPH) announces the conditional acquisition of the entire share capital of Putney, Inc, a leading developer of generic companion animal pharmaceuticals in the US, based in Portland, Maine.
OP animal health parent leashes $200M acquisition  Kansas City Business Journal
Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?
Pet medicines mammoth Dechra Pharmaceuticals (LSE: DPH) cheered the market with terrific half-year numbers in Monday business, propelling the stock 8% higher from the end of last week.
Dechra Pharmaceuticals PLC: Half-Yearly Financial Report 2016
"All our business units are performing well, we are in the process of launching several new products, our international expansion plans are progressing as expected and we have made two strategic acquisitions.
Dechra shares jump on strong revenue  shropshirestar.com
Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On ...
For example, Dechra (LSE: DPH) has been able to increase its earnings at a double-digit rate in each of the last three years, with it rising at an annualised rate of 23% during the period.
Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than GlaxoSmithKline plc?
While shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have disappointed in the last year, it has not been the same story for a number of its pharmaceutical rivals. In fact, shares in Genus (LSE: GNS) and Dechra (LSE: DPH) have soared in the last 12 ...
Dechra� Pharmaceuticals PLC (Dechra or the Group) : Trading Update
The Board of Dechra Pharmaceuticals PLC (LSE:DPH), issues the following unaudited Trading Update ahead of the Group's half-year financial results for the period ended 31 December 2015, which will be announced on Monday, 22 February 2016.
Veterinary drugs firm in �4 million deal  shropshirestar.com
Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC ...
AstraZeneca (LSE: AZN), Dechra Pharmaceuticals (LSE: DPH) and Tissue Regenix (LSE: TRX) represent a great healthcare combination.
International Veterinary Pharmaceutical Business Dechra Pharmaceuticals PLC ...  PR Newswire (press release)
Dechra Pharmaceuticals grows profit again  Interactive Investor
Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra ...
One of the major concerns of investors in AstraZeneca (LSE: AZN) in recent years has been its ability to pay dividends. That's because it has been subjected to a patent cliff, where a number of key drugs have come off-patent and with the company ...
Are AstraZeneca plc, Indivior PLC & Dechra Pharmaceuticals plc Set To Double ...
If you are looking for relatively stable cash flows and solid balance sheets in a volatile market, there is a good chance that you may be right to invest in the pharmaceuticals sector right now. That works in theory, at least - but is there also a ...
Dechra Pharmaceuticals plc (LON:DPH) Receives GBX 1205.71 Average PT from ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have been given an average rating of “Buy” by the nine brokerages that are covering the stock, Marketbeat reports.